ICD-O-3 Implementation Guidelines
These documents address the implementation of ICD-O-3 for cases diagnosed on or after January 1, 2021.
ICD O 3.2 Implementation Documents
- 2021 ICD O 3.2 Coding Guidelines – 10/05/2020
- 2021 ICD O 3.2 Tables 1-5 (tables with new term, new codes, changed behaviors, etc) – 10/01/2020
- 2021 ICD O 3.2 Table 6 Numeric (combined tables 1-5 in numeric order) – 11/10/2020
- 11/10/20 Paraganglioma, NOS histology code corrected (8680 is correct code)
- 2021 ICD O 3.2 Table 7 Alpha Table (combined tables 1-5 in alpha order)- 11/10/2020
- 11/10/20 Paraganglioma, NOS histology code corrected (8680 is correct code)
- 2021 ICD O 3.2 Coding Table Excel (full list of ICD 3.2 histology codes)- 10/01/2020
Annotated Histology List
- Annotated Histology List
- Updated 11/10/20-Superficial Spreading Adenocarcinoma (8143/3) was changed to TRUE.
2018 ICD-O-3 Implementation Guidelines (December 2017)
These documents address the implementation of ICD-O-3 for cases diagnosed on or after January 1, 2018.
- 2018 ICD O 3 Coding Guidelines – 1/10/18
- 2018 ICD O 3 Coding Table .pdf – 8/22/18 (sorted by numeric order)
- 2018 ICD 0 3 Coding Table .pdf – 8/22/18 (sorted by alpha order)
- Errata – 8/22/18
*The tables were originally posted on 12/20/17.
2014 ICD-O-3 Implementation Guidelines (December 2013)
This document addresses the implementation of ICD-O-3 for cases diagnosed on or after January 1, 2014.
- Guidelines for ICD-O-3 Update Implementation – Revised April 2014
-
ICD-O-3 Implementation Guidelines (November 2000)
This document addresses the implementation of ICD-O-3 for cases diagnosed on or after January 1, 2001
